Xenobiotic-induced liver injury and fibrosis

Abstract

Introduction: Many different drugs and xenobiotics (chemical compounds foreign to an organism) can injure the bile duct epithelium and cause inflammatory bile duct diseases (cholangiopathies) ranging from transient cholestasis to vanishing bile duct syndrome, sclerosing cholangitis with development of biliary fibrosis and cirrhosis. Animal models of xenobiotic-induced liver injury have provided major mechanistic insights into the molecular mechanisms of xenobiotic-induced cholangiopathies and biliary fibrosis including primary biliary cirrhosis and primary sclerosing cholangitis.

Areas covered: In this review, the authors discuss the basic principles of xenobiotic-induced liver and bile duct injury and biliary fibrosis with emphasis on animal models. A PubMed search was performed using the search terms “xenobiotic,” “liver injury,” “cholestasis,” and “biliary fibrosis.” Reference lists of retrieved articles were also searched for relevant literature.

Expert opinion: Xenobiotic-induced cholangiopathies are underestimated and frequently overlooked medical conditions due to their often transient nature. However, biliary disease may progress to vanishing bile duct syndrome, biliary fibrosis, and cirrhosis. Moreover, xenobiotics may prime the liver for subsequent liver disease by other agents and may also contribute to the development of hepatobiliary cancer though interaction with resident stem cells.

Keywords::

• 3,5-diethoxycarbonyl-1,4-dihydrocollidine
• alpha-naphthylisothiocyanate
• bile duct epithelial cells
• cholangiocytes
• cholestasis
• fibrosis
• hepatic stellate cells
• Mallory-Denk bodies
• myofibroblasts
• portal fibroblasts
• primary biliary cirrhosis
• primary sclerosing cholangitis
• xenobiotic

Notes

This box summarizes key points contained in the article.